By rray, 26 March, 2024 These include abnl liver kidney fxn bleeding clotting d o concomitant antiplatelet or NSAID use EtOH and anemia
By rray, 26 March, 2024 These include abnl liver kidney fxn bleeding clotting d o concomitant antiplatelet or NSAID use EtOH and anemia
By rray, 26 March, 2024 If CHA2DS2 VASc 2 or equivalent risk of stroke interrupting or continuing DOAC both acceptable A
By rray, 26 March, 2024 If thromboembolism risk 5 continue warfarin in preference to interruption and bridging A